Hyundai Pharmaceutical Co (XKRX:004310) Change In Receivables : ₩3,122 Mil (TTM As of May. 2024)

Hyundai Pharmaceutical Co Change In Receivables Chart

Hyundai Pharmaceutical Co Annual Data
	Trend	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23
Change In Receivables		Get a 7-Day Free Trial					-1,434.49	2,978.37	1,072.02	-840.24	3,000.66

Hyundai Pharmaceutical Co Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Change In Receivables	Get a 7-Day Free Trial															-4,461.90	177.30	1,900.99	1,146.93	-103.71

Hyundai Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,122 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyundai Pharmaceutical Co  (XKRX:004310) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hyundai Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in May. 2024 is calculated as:

2. In Ben Graham's calculation of liquidation value, Hyundai Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Hyundai Pharmaceutical Co's liquidation value for the quarter that ended in May. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyundai Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Pharmaceutical Co Business Description